Nanoparticles Dual Targeting Both Myeloma Cells and Cancer-Associated Fibroblasts Simultaneously to Improve Multiple Myeloma Treatment

Cancer-associated fibroblasts (CAFs) and myeloma cells could mutually drive myeloma progression, indicating that drug delivery to kill both CAFs and myeloma cells simultaneously could achieve better therapeutic benefits than to kill each cell type alone. Here, we designed a dual-targeting drug deliv...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Honglan, Liu, Huiwen, Sun, Chunyan, Liu, Chunying, Jiang, Ting, Yin, Yanxue, Xu, Aoshuang, Pang, Zhiqing, Zhang, Bo, Hu, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922689/
https://www.ncbi.nlm.nih.gov/pubmed/33670464
http://dx.doi.org/10.3390/pharmaceutics13020274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922689/
https://www.ncbi.nlm.nih.gov/pubmed/33670464
http://dx.doi.org/10.3390/pharmaceutics13020274

Ejemplares similares